ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2026
[Advancement in the role of exosomes for hepatitis B virus infection diagnosis and treatment: mechanisms and clinical applications].
Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Hepatitis B virus (HBV) infection is a major global public health problem, causing approximately one million deaths annually. Exosomes are nanosized vesicles (30-150 nm) enclosed in a lipid bilayer membrane, secreted by almost all cells, and carry bioactive substances such as proteins, nucleic acids, and lipids, thereby playing a key role in intercellular communication. Recent research results have shown that exosomes play an important advanced role in the diagnosis and treatment of HBV infection. This review systematically summarizes the dual role of exosomes in HBV infection (promoting viral transmission and participating in immune regulation), their application as novel biomarkers in the diagnosis of HBV-related liver diseases, the latest research progress in exosome-based therapeutic strategies, and their current status in clinical translation, with the aim of providing updated and more precise biological markers and therapeutic targets for clinical diagnosis and treatment and offering perspectives for future research directions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.